Transfer of IGF2BP3 Through Ara-C-Induced Apoptotic Bodies Promotes Survival of Recipient Cells

Cytosine arabinoside (Ara-C) has been the standard therapeutic agent for myelodysplastic syndromes (MDS) and adult acute myeloid leukemia (AML) patients for decades. Considerable progress has been made in development of new treatments for MDS/AML patients, but drug resistance remains a major clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Junjie, Li, Hongjiao, Bi, Jingjing, Pang, Xingchen, Li, Xiang, Wang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124970/
https://www.ncbi.nlm.nih.gov/pubmed/35615150
http://dx.doi.org/10.3389/fonc.2022.801226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124970/
https://www.ncbi.nlm.nih.gov/pubmed/35615150
http://dx.doi.org/10.3389/fonc.2022.801226

Ejemplares similares